https://www.selleckchem.com/pr....oducts/azd5153-6-hyd
OBJECTIVES To compare both the concordance between the 4Kscore® and SelectMDx® for informing decision to perform prostate biopsy (P and the performance of these tests for detecting clinically significant prostate cancer (csPCa). Several biomarkers were developed to inform decisions whether to perform a PB based on the probability of detecting csPCa. There is a paucity of studies directly comparing them METHODS Between 11/2018 and 4/2019, all new referrals with the diagnosis of elevated PSA were advised to un
Like
Comment
Share
